EGR1 and hyperlipidemia: Many studies have also supported our results by demonstrating that hyperglycemia, hyperinsulinemia, insulin resistance, and hyperlipidemia often occur in D-galactose induced mice [68,69], which may be consequences of the high level of Egr1 expression and the decrease in palmitoleic acid in these mice.